Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ("Sana Biotechnology, Inc." or the "Company") of a class action securities ...

NEW YORK, NY / ACCESS Newswire / April 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

Consumer spending accounts for roughly 70% of America's GDP, and in 1994, Jeff Bezos changed the way Americans consume. Amazon started as an online bookstore and blossomed into a $1.9 ...

Stifel head of biotech research Paul Matteis suggests looking for biotech names not dependent on the FDA while this sector ...

Beam Therapeutics Inc.’s BEAM share price has surged by 5.12%, which has investors questioning if this is right time to sell.

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: ...

Sana Biotechnology, Inc.’s SANA share price has surged by 12.75%, which has investors questioning if this is right time to ...

From researching climate change policy to exploring the potential of cell therapy to combat disease to fostering leadership skills in youth, McMaster students have made . . .

Sana faces a class action for allegedly misleading investors about finances and drug programs, says Robbins LLP.

Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. (“Sana” or the “Company”) (NASDAQ: SANA) and ...